Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
08/2001
08/09/2001CA2399516A1 Sulfate of quinolonecarboxylic acid derivatives and the use thereof
08/09/2001CA2399214A1 Novel heterocyclic amide derivatives
08/08/2001EP1121355A1 Quinoline derivatives and their use as antibacterial agents
08/08/2001EP1121342A1 Diaminopropionic acid derivatives
08/08/2001CN1307565A Quinolones used as MRS inhibitor and bactericides
08/07/2001US6271416 O-(hydrocarbonoxyacetamido)benzoic acid derivatives as intermediates
08/07/2001US6271253 Cyclooxygenase inhibitors
08/07/2001US6271247 Binding to neuropeptide receptors
08/07/2001US6271235 HIV protease inhibitors
08/07/2001CA2104782C 1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines
08/02/2001WO2001055111A1 Biaryl compounds, their preparation and their use in therapy
08/02/2001WO2001055085A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
08/02/2001WO2001055082A2 Intermediates for biologically active compounds
08/02/2001WO2001054691A1 Nitrate salts of antimicrobial agents
08/02/2001WO2001054481A2 Enhanced propertied pharmaceuticals
08/02/2001WO2000076971A3 Serine protease inhibitors
08/02/2001CA2397831A1 Enhanced propertied pharmaceuticals
08/02/2001CA2397754A1 Nitrate salts of antimicrobial agents
08/02/2001CA2395298A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
08/01/2001EP1119550A1 2-substituted heterocyclic sulfonamides
08/01/2001EP1119542A1 Prostaglandin receptor ligands
08/01/2001EP1119357A1 C3a receptor ligands
08/01/2001CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
08/01/2001CN1306508A Hydroxamic acid derivatives as inhibitors or prodn. of human CD23 and of TNF release
07/2001
07/31/2001US6268500 Heating slurry comprising mixture of nitroquinoline position isomer hydrohalide salts in wet dimethylformamide to form a solution; cooling solution until a precipitate comprising 5-nitroquinoline hydrohalide is formed; collecting the
07/31/2001US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis.
07/31/2001CA2016908C Excitatory amino acid antagonists
07/26/2001WO2001053274A1 Amide compounds for inhibiting protein kinases
07/26/2001WO2001053266A1 Therapeutic morpholino-substituted compounds
07/26/2001WO2001053265A1 Process for the preparation of quinolylpropenal
07/26/2001WO2001053264A1 Process for preparing quinolylacrylonitrile and intermediates therefor
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001WO2001052829A2 Statin-type bone growth stimulators
07/26/2001WO1999015129A3 SELECTIVE cPLA2 INHIBITORS
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2397659A1 Statin-type bone growth stimulators
07/26/2001CA2394703A1 Amide compounds for inhibiting protein kinases
07/25/2001EP1118640A1 Bridged perinone, quinophthalone and perinone-quinophthalone
07/25/2001EP1117661A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
07/25/2001EP1117659A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/25/2001EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
07/25/2001EP1117649A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/25/2001EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
07/25/2001EP1117647A1 Method for preparing 4-hydroxyquinolines and/or tautomeric forms
07/25/2001EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
07/25/2001EP1117639A1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
07/25/2001EP0876346B1 Antimalarial quinolin derivatives
07/25/2001EP0646117B1 Methods and intermediates for the asymmetric synthesis of camptothecin and camptothecin analogs
07/25/2001CN1305471A Dihydropyrimidines
07/25/2001CN1305453A Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same
07/25/2001CN1304936A Quinoline-4-radical derivative II
07/24/2001US6265421 Phospholamban inhibitors and a method for increasing coronary flow
07/24/2001US6265417 Muscle relaxants
07/24/2001US6265406 Viricides
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001WO2001012597A3 Method for preparing quinoline-5,8-diones
07/19/2001WO2000076970A3 Serine protease inhibitors
07/19/2001CA2397575A1 Antibacterial agents
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/19/2001CA2396007A1 Piperidine and piperazine derivatives
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors
07/18/2001EP1115405A1 Use of certain drugs for treating nerve root injury
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001EP0636025B1 Compounds useful for treating allergic or inflammatory diseases
07/17/2001US6262269 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries
07/17/2001US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
07/12/2001WO2001049679A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
07/12/2001WO2001049675A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
07/12/2001WO2001049288A1 Novel compounds and compositions as protease inhibitors
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease
07/12/2001CA2396257A1 Novel compounds and compositions as protease inhibitors
07/12/2001CA2395795A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/11/2001EP1114522A1 Rf receiver having cascaded filters and an intermediate amplifier stage
07/11/2001EP1114474A1 Electro-luminescent arrangements with thiophene carboxylate metal complexes
07/11/2001EP1114033A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
07/11/2001EP1114032A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
07/11/2001EP1114031A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
07/11/2001EP1114028A1 Aza-bicycles which modulate the inhibition of cell adhesion
07/11/2001CN1303372A New heterocyclically substituted amides, their production and their use
07/11/2001CN1302804A Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds
07/11/2001CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
07/11/2001CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same
07/10/2001US6258829 Antiarrthmia agents and cardiovascular disorders
07/10/2001US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds.
07/10/2001US6258806 Peptides with cyclic diazaalkanes for prevention of premature metabolism method for inhibiting an hiv protease in a mammal in need of such protease inhibition, comprising administering to said mammal an effective dosage
07/10/2001CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments
07/05/2001WO2001047898A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
07/05/2001WO2001047892A1 Tricyclic protein kinase inhibitors
07/05/2001WO2001047891A1 Heterocyclic compounds having sulfonamide groups
07/05/2001WO2001047890A1 Quinoline and quinazoline derivatives and drugs containing the same
07/05/2001WO2001047889A1 Tricyclic compounds
07/05/2001WO2001047483A1 Use of methylchinolinium compounds for dyeing keratin containing fibers
07/05/2001US20010007031 Enantiomers of 8-aminoquinoline; antiparasitic compounds for treatment or prevention of Pneumocystis carinii pneumonia, toxoplasmosis, malaria, leishmaniasis, or trypsonosomia
07/05/2001DE19960924A1 Amphiphile Polyamine, deren Anwendungen und Verfahren zu ihrer Synthese Amphiphilic polyamines, their applications and methods for their synthesis
07/05/2001CA2396579A1 Tricyclic protein kinase inhibitors